ENTITY

Medigene AG (MDG1 GR)

Analysis

Health Care • Germany

Medigene AG operates as a biopharmaceutical company. The Company provides research, development, and commercialization of drugs for the treatment of cancer and autoimmune diseases.

Refresh

Focused

No publications yet

There aren’t any podcasts right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00